Your child has a condition called Myopia or Nearsightedness. This means that your child’s vision close up is clear but far away is blurry. Myopia will likely continue to increase until he/she is approximately twenty or twenty-one years of age. As this occurs, your child’s vision will likely get significantly worse every six months to a year.

Your child’s nearsightedness will likely continue to progress even if glasses or soft contact lenses are worn on a regular basis to correct your child’s nearsightedness. Traditional glasses or contact lenses do not slow down the progression of myopia. That’s our goal - to slow down myopia progression.

There are four therapies for slowing down myopia progression. Regulatory approval for each therapy varies from country to country. The therapies are Orthokeratology (Ortho-K), Atropine Drops, Specialty Dual Focused Contact Lenses, or Myopia Spectacles.

• Orthokeratology (Ortho-K) is the use of specially designed and fitted contact lenses to gently reshape the cornea overnight which enables clear vision without contacts or glasses the next morning.

• Atropine Eye Drops are low dose eye drops administered at bedtime. Atropine drops are approved by regulatory authorities such as the FDA but not for myopia management indication

• Specialty Daytime Dual Focused Soft Contact Lenses worn during the day, such as MiSight and
  NaturalVue.

• Myopia Spectacles such as MiyoSmart are specially designed glasses worn during the day.